What is Palvella Therapeutics's debt-to-assets?

Palvella Therapeutics (PVLA) reported debt-to-assets of 0× in Q1 2026.

What is the long-term trend for Palvella Therapeutics's debt-to-assets?

Over 3 years (2020 to 2025), Palvella Therapeutics's debt-to-assets has grown at a -59.7% compound annual growth rate (CAGR), from 0.2× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Palvella Therapeutics PVLA Debt-to-assets

Debt-to-assets at other companies

Relay Therapeutics, Inc.RLAY

0×0.0×

Viridian Therapeutics, Inc.VRDN

0×0.0×

ANI PharmaceuticalsANIP

0.2×0.0×

PrecigenPGEN

0.7×+0.7×

Arcutis Biotherapeutics, Inc.ARQT

0.2×-0.1×

Kodiak Sciences IncKOD

0.2×0.0×

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's debt-to-assets?: Palvella Therapeutics (PVLA) reported debt-to-assets of 0× in Q1 2026.
What is the long-term trend for Palvella Therapeutics's debt-to-assets?: Over 3 years (2020 to 2025), Palvella Therapeutics's debt-to-assets has grown at a -59.7% compound annual growth rate (CAGR), from 0.2× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.